PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) announced inducement equity grants approved Nov. 24, 2025, to 15 new employees under Nasdaq Listing Rule 5635(c)(4).

The company approved non-statutory stock options to purchase an aggregate of 2,000 shares and 8,200 restricted stock units (RSUs). Options have an exercise price of $79.83 (closing price on Nov. 24, 2025), a 10-year term, and vest over four years: 25% at first anniversary then 6.25% each subsequent three months. RSUs vest over four years with 25% on each annual anniversary. Grants were approved by the Compensation Committee and issued as inducements material to each hire's acceptance of employment.

WARREN, N.J., Dec. 1, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on Nov. 24, 2025 , the company approved non-statutory stock options to purchase an aggregate of 2,000 shares of its common stock and 8,200 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 15 new employees. The awards were made pursuant to the Nasdaq inducement grant exception as a component of the new hires' employment compensation.

The inducement grants were approved by PTC's Compensation Committee on Nov. 24, 2025, and are being made as an inducement material to each employee's acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4).

All stock option awards have an exercise price of $79.83 per share, the closing price of PTC's common stock on Nov. 24, 2025, the date of the grant. The stock options each have a 10-year term and vest over four years, with 25% of the original number of shares vesting on the first anniversary of the applicable employee's new hire date and 6.25% of the original number of shares vesting at the end of each subsequent three-month period thereafter until fully vested, subject to the employee's continued service with the company through the applicable vesting dates. The RSUs each will vest over four years with 25% of the original number of shares vesting on each annual anniversary of the applicable employee's new hire date until fully vested, subject to the employee's continued service with the company through the applicable vesting dates.

ABOUT PTC THERAPEUTICS, INC.
PTC is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of clinically differentiated medicines for children and adults living with rare disorders. PTC is advancing a robust and diversified pipeline of transformative medicines as part of its mission to provide access to best-in-class treatments for patients with unmet medical needs. The company's strategy is to leverage its scientific expertise and global commercial infrastructure to optimize value for patients and other stakeholders. To learn more about PTC, please visit www.ptcbio.com and follow on Facebook, X, and LinkedIn.

For more information please contact:

Investors:
Ellen Cavaleri
+1 (615) 618-8228
ecavaleri@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-302629535.html

SOURCE PTC Therapeutics, Inc.

FAQ

What equity awards did PTC Therapeutics (PTCT) grant on Nov. 24, 2025?

PTC granted an aggregate of 2,000 stock options and 8,200 RSUs to 15 new employees as inducement awards.

What is the exercise price and term for PTCT's Nov. 24, 2025 stock options?

The options carry an exercise price of $79.83 and a 10-year term.

How do the PTCT options vest for the Nov. 24, 2025 inducement grants?

Options vest over four years: 25% at the first anniversary of hire, then 6.25% every three months until fully vested.

What is the RSU vesting schedule for PTCT's inducement grants?

Each RSU grant vests over four years with 25% vesting on each annual anniversary of the employee's hire date.

Under what Nasdaq rule were PTC's inducement grants approved?

The grants were made under the Nasdaq Listing Rule 5635(c)(4) inducement grant exception and approved by the Compensation Committee.